Ritonavir

Ritonavir crystals grown in low Earth orbit landed in a spacecraft in the Utah desert Wednesday, completing the manufacturing portion of a proof-of-concept manufacturing effort.

There are drug-drug interactions between the COVID-19 treatment ritonavir/nirmatrelvir and various classes of commonly used CV medications, according to a review paper.

New guidance from the Infectious Diseases Society of America provides information on how to manage drug interactions between Paxlovid — an oral antiviral authorized for COVID-19 — and commonly prescribed medications.

Older patients with no preexisting nodal pathology who received lopinavir/ritonavir combination therapy for treatment of COVID-19 infection may experience bradycardia during hospitalization, researchers reported.

Researchers in China found that hospitalized patients with milder cases of COVID-19 were treated earlier with an assortment of antivirals compared with patients who experienced more severe disease, suggesting that the timing of antiviral therapy may significantly slow COVID-19 progression.

BOSTON — Triple combination therapy with lonafarnib, ritonavir, and Lambda for chronic hepatitis D appeared safe and tolerable for up to 6 months in most patients and led to high rates of RNA decline, according to data presented at The Liver Meeting 2019.

From 2013 through 2016, an estimated 2.4 million adults in the United States had a current hepatitis C virus infection. A study published in The American Journal of Public Health reported that the infection rate increased more than twofold between 2004 and 2014 as a result of the opioid epidemic.

From 2013 through 2016, an estimated 2.4 million adults in the United States had a current hepatitis C virus infection. A study published in The American Journal of Public Health reported that the infection rate increased more than twofold between 2004 and 2014 as a result of the opioid epidemic.